Key result
Comorbidity indices fail to predict unfavorable functional status at discharge.
Why the study?
The prognostic relevance of comorbidity burden in patients with acute ischemic stroke treated with intravenous thrombolysis remains uncertain.
Does comorbidity burden, as measured by CCI and ECI indices, predict unfavorable functional status at discharge in patients with acute ischemic stroke treated with intravenous thrombolysis?
Observational (n=106)
No
Does comorbidity burden, as measured by CCI and ECI indices, predict unfavorable functional status at discharge in patients with acute ischemic stroke treated with intravenous thrombolysis?
Effect estimate: AUC 0.645 (95% CI 0.531-0.760)
Comorbidity indices showed modest discriminatory performance and were not independently associated with short-term functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis, whereas admission stroke severity and glucose levels were stronger predictors.
Comorbidity indices should not guide discharge planning; leaves open their value in prospective cohorts or other endpoints.
Background The prognostic relevance of comorbidity burden in patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis (IVT) remains uncertain. This study examined the association between four comorbidity indices and early in‐hospital outcomes. Methods This single‐center retrospective study included 106 patients with AIS treated with IVT between January and December 2024. Comorbidity burden was assessed using the Charlson Comorbidity Index (CCI; 1987 and 2011 versions) and the Elixhauser Comorbidity Index (ECI; 2009 and 2017 versions). The primary outcome was unfavorable functional status at discharge, defined as a modified Rankin scale (mRS) score of 3–6. Multivariable logistic regression was used to identify factors associated with the primary outcome, and receiver operating characteristic (ROC) analyses assessed the discriminatory performance of the indices. Mortality comparisons were exploratory because only 10 in‐hospital deaths occurred. Results The median age was 68 years, and 60 patients (56.6%) were men. Unfavorable functional outcome (mRS 3–6) occurred in 73 patients (68.9%). Higher admission National Institutes of Health Stroke Scale (NIHSS) scores and glucose levels were independently associated with unfavorable functional status at discharge, whereas none of the four comorbidity indices remained significant after multivariable adjustment. The comorbidity indices showed limited to modest discriminatory performance, with an AUC of 0.645 (95% CI 0.531–0.760) for CCI 1987. Hemorrhagic transformation (HT) occurred exclusively in patients with an unfavorable outcome and was more frequent among nonsurvivors. Exploratory comparisons also showed higher prestroke mRS, admission NIHSS, CCI 1987, and CCI 2011 scores among nonsurvivors; no multivariable mortality analysis was performed. Conclusions None of the evaluated comorbidity indices was independently associated with functional status at hospital discharge. Their discriminatory performance was modest, whereas admission stroke severity and glucose level showed stronger associations with short‐term outcome. Given the retrospective single‐center design, modest sample size, and limited number of deaths, the findings should be considered exploratory and hypothesis‐generating and require confirmation in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Battakova et al. (2026) conducted an observational in Acute ischemic stroke (AIS) (n=106). Comorbidity burden (CCI and ECI) was evaluated on Unfavorable functional status at discharge (mRS score 3-6) (AUC 0.645, 95% CI 0.531-0.760). Comorbidity indices (CCI and ECI) were not independently associated with unfavorable functional status at discharge, showing limited discriminatory performance (AUC 0.645; 95% CI 0.531-0.760 for CCI 1987).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: